November 9, 2006
The drug imatinib (Gleevec) is generally considered to be the most significant new entrant in the armamentarium of anticancer drugs in the past 20 years. Its approval in May 2001 was the cover story of Time magazine. In patients whose cancers had grown despite earlier ...
October 31, 2006
Studies show that Asian populations have a lower incidence of chronic diseases, such as cancer, than their Western counterparts. One such study, by the National Cancer Institute, found that whites had a 65 percent higher rate of cancer mortality than Asian-Pacific Islanders from the years ...
October 27, 2006
Cancer, diabetes, inflammation, malaria. The list of diseases ripe for new treatments is long. Yet the pace of drugs coming to market is actually flat.
A key reason is the drug discovery process itself, says Jim Wells, director of the Small Molecule Discovery Center (SMDC) ...
October 27, 2006
With one in every eight US women diagnosed with breast cancer in her lifetime, this disease has affected the population on a grand scale.
Each year, roughly 200,000 women are diagnosed with breast cancer and more than 40,000 die. With exceptionally high rates in the ...
October 27, 2006
It has been a robust year for stem cell research at UCSF. Previously made up of numerous pioneering labs working relatively independently, the research program here has coalesced into one of the premier stem cell institutes in the United States.
Scientists in some 60 labs ...
October 18, 2006
As part of UCSF Today's new On the Spot web feature, Dr. Donald Abrams, the new director of clinical programs at the Osher Center for Integrative Medicine and an expert in complementary therapies, agreed to answer your questions.
Below we've published some of the questions ...
Podcasts
